Recalls / Class II
Class IID-0016-2017
Product
Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS) Intravitreal Injection, 1 mL Total Volume in a 2 mL Vial, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-003-35
- Affected lot / code info
- All unexpired lots; Expirations dates of 09/21/2016 to 2/2/2017
Why it was recalled
Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
Recalling firm
- Firm
- Leiter's Compounding
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 17 Great Oaks Blvd, N/A, San Jose, California 95119-1359
Distribution
- Quantity
- 76,315 total units, all products
- Distribution pattern
- Nationwide
Timeline
- Recall initiated
- 2016-09-20
- FDA classified
- 2016-10-12
- Posted by FDA
- 2016-10-19
- Terminated
- 2017-05-03
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0016-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.